comparemela.com
Home
Live Updates
US-based investor Janus Henderson marks down PharmEasys valuation by half to $2.8 bn : comparemela.com
US-based investor Janus Henderson marks down PharmEasy's valuation by half to $2.8 bn
Janus Henderson reduced the valuation of its holding in the firm by half which translates into an approximate valuation of $2.8 billion as of December 31, 2022.
Related Keywords
Quebec
,
Canada
,
Abu Dhabi
,
Neuberger Berman
,
Ratan Tata
,
Janus Henderson
,
Exchange Commission
,
Economic Times
,
New York Based
,
Amansa Capital
,
Apah Capital
,
Pine Labs
,
Tiger Global Backed Upstox
,
Pharmeasy
,
Pharmeasy Valuation
,
Pharmeasy Funding
,
Harmeasy Funding Round
,
Harmeasy Investors
,
Harmeasy Profitability
,
Harmeasy Net Profit
,
Harmeasy Net Revenue
,
Harmeasy Revenue
,
Harmeasy Profit
,
Harmeasy Run Rate
,
Harmeasy Founders
,
Harmeasy Owner
,
Blackstone
,
Bu Dhabi Adq
,
Caisse De Depot Et Placement Du Quebec
,
Canada Pension Fund
,
Anada Cdpq
,
Startups
,
Indian Startups
,
Byjus
,
La
,
Swiggy
,
Funding Winter
,
Startups Funding
,
Tartups Funding Winter
,
Pharmeasy Ipo
,
Harmeasy App
,
Harmeasy App On Play Store
,
Harmeasy App On Apple Store
,
Harmeasy App On Google Play Store
,
Pharmeasy Thyrocare
,
comparemela.com © 2020. All Rights Reserved.